Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical Trials, Phase III as Topic

"Clinical Trials, Phase III as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.

This graph shows the total number of publications written about "Clinical Trials, Phase III as Topic" by people in Harvard Catalyst Profiles by year, and whether "Clinical Trials, Phase III as Topic" was a major or minor topic of these publication.
Bar chart showing 558 publications over 31 distinct years, with a maximum of 45 publications in 2019
To see the data from this visualization as text, click here.
Related Networks
Similar Concepts
Top Journals 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.